Skip to main content
. 2015 Aug 4;10(8):e0132244. doi: 10.1371/journal.pone.0132244

Table 2. Association of HbA1c, insulin, glucose, and HOMA-IR tertiles with metabolic syndrome criteria.

HbA1c Insulin Glucose HOMA-IR*
tertiles tertiles tertiles tertiles
(%) (pmol/L) (mmol/L)
< 5.3 ≥ 5.3 and < 5.5 ≥ 5.5 < 26.4 ≥ 26.4 and < 42.6 ≥ 42.6 < 5.00 ≥ 5.00 and < 5.55 ≥ 5.55 < 1.029 ≥ 1.029 and < 1.688 ≥ 1.688
N 954 953 1293 1036 1093 1071 959 1155 1086 1067 1066 1067
Average 5.08 5.35 5.66 19.33 33.71 66.17 4.61 5.24 5.96 0.73 1.33 2.75
High Waist Circumf. (%) 19.2 25.1 37.3 9.9 23.3 51.0 21.7 24.3 38.2 10.6 24.0 50.1
OR 1.00 1.22 1.98 1.00 2.67 9.13 1.00 1.08 1.82 1.00 2.56 7.90
(Reference) (0.97,1.52) (1.62,2.43) (Reference) (2.08,3.43) (7.22,11.63) (Reference) (0.88,1.33) (1.49,2.23) (Reference) (2.01,3.27) (6.29,9.99)
High Triglycerid. (%) 28.0 29.7 39.4 16.3 31.1 51.4 29.3 32.6 37.0 17.3 30.6 51.5
OR 1.00 0.99 1.44 1.00 2.26 5.25 1.00 1.11 1.23 1.00 2.05 4.80
(Reference) (0.81,1.21) (1.19,1.74) (Reference) (1.84,2.79) (4.28,6.45) (Reference) (0.92,1.34) (1.01,1.49) (Reference) (1.67,2.52) (3.93,5.87)
Low HDL-cholest. (%) 6.1 8.5 10.1 4.1 6.5 14.6 9.1 8.1 8.2 4.5 7.1 13.6
OR 1.00 1.55 1.97 1.00 1.68 4.18 1.00 0.89 0.93 1.00 1.67 3.53
(Reference) (1.09,2.23) (1.40,2.79) (Reference) (1.14,2.50) (2.96,6.02) (Reference) (0.65,1.21) (0.68,1.29) (Reference) (1.16,2.45) (2.52,5.01)
High Blood Pressure (%) 42.3 51.2 61.5 41.6 50.9 65.4 42.2 48.7 66.3 40.7 51.5 66.0
OR 1.00 1.10 1.43 1.00 1.37 2.48 1.00 1.16 1.94 1.00 1.45 2.49
(Reference) (0.91,1.34) (1.19,1.72) (Reference) (1.15,1.64) (2.06,2.98) (Reference) (0.97,1.39) (1.61,2.35) (Reference) (1.21,1.74) (2.07,2.99)
High Glucose (%) 18.7 29.4 48.6 20.2 34.1 47.1 13.6 32.9 55.3
OR 1.00 1.50 3.07 1.00 1.98 3.34 1.00 3.02 7.35
(Reference) (1.21,1.88) (2.51,3.77) (Reference) (1.62,2.43) (2.74,4.08) (Reference) (2.42,3.77) (5.93,9.16)
Metabolic Syndrome (%) 12.4 19.1 33.6 6.5 17.6 44.4 9.7 10.6 47.9 5.3 17.1 46.5
OR 1.00 1.38 2.68 1.00 2.97 11.36 1.00 1.02 7.03 1.00 3.47 14.40
(Reference) (1.07,1.79) (2.13,3.39) (Reference) (2.22,4.01) (8.65,15.13) (Reference) (0.77,1.36) (5.50,9.06) (Reference) (2.55,4.78) (10.80,19.53)
2+-non-glyc.-criteria (%) 26.0 31.8 48.9 15.3 32.8 62.2 29.5 32.9 47.9 16.4 32.4 62.1
OR 1.00 1.12 2.10 1.00 2.61 8.94 1.00 1.08 1.73 1.00 2.34 7.83
(Reference) (0.91,1.38) (1.74,2.54) (Reference) (2.11,3.24) (7.24,11.09) (Reference) (0.89,1.30) (1.43,2.10) (Reference) (1.90,2.89) (6.38,9.65)
3+-non-glyc.-criteria (%) 8.1 11.2 17.0 3.3 7.7 26.7 9.7 10.6 17.4 3.2 8.7 26.0
OR 1.00 1.25 1.87 1.00 2.36 10.20 1.00 1.03 1.62 1.00 2.78 9.84
(Reference) (0.92,1.72) (1.42,2.50) (Reference) (1.58,3.59) (7.16,14.99) (Reference) (0.77,1.37) (1.24,2.13) (Reference) (1.87,4.21) (6.90,14.48)
Insulin Resistance (%) 6.5 10.0 16.9 0.0 0.0 35.1 2.9 8.4 23.1
OR 1.00 1.50 2.66 1.00 3.03 9.84
(Reference) (1.07,2.11) (1.97,3.64) (Reference) (2.00,4.74) (6.64,15.13)

Adjusted odds ratios and their confidence interval calculated from a logistic regression model adjusted for age (continuous). All tests for linear trend, calculated from models introducing each predictor as continuous variable, were statistically significant at a level α<0.001 except for glucose and high triglycerides (p = 0.03) and for glucose and Low HDL-cholesterol (p = 0.31).

*HOMA-IR: Homeostatic Model Assessment—Insulin Resistance.

OR: Odds Ratio.

Outcome variable directly related to the predictor because of a formula or because of a diagnostic criterion.